Neuroprotective Potency of Saffron Against Neuropsychiatric Diseases, Neurodegenerative Diseases, and Other Brain Disorders: From Bench to Bedside

被引：45
作者：
Bian, Yaqi
Zhao, Chen
Lee, Simon Ming-Yuen [1 ]
机构：
[1] Univ Macau, State Key Lab Qual Res Chinese Med, Macau, Peoples R China
来源：
FRONTIERS IN PHARMACOLOGY | 2020年 / 11卷
关键词：
saffron; saffron constituents; anti-depressant effect; anxiolytic effect; neuroprotective effects; traditional Chinese medicine; CROCUS-SATIVUS-L; TO-MODERATE DEPRESSION; MILD COGNITIVE IMPAIRMENT; DOUBLE-BLIND; AQUEOUS EXTRACT; ACTIVE CONSTITUENTS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; CEREBRAL-ISCHEMIA; SAFETY EVALUATION;
D O I：
10.3389/fphar.2020.579052
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The increasing morbidity rates of brain disorders and conditions such as anxiety, depression, Alzheimer's disease, and Parkinson's disease have become a severe problem in recent years. Although researchers have spent considerable time studying these diseases and reported many positive outcomes, there still are limited drugs available for their treatment. As a common traditional Chinese medicine (TCM), saffron was employed to treat depression and some other inflammatory diseases in ancient China due to its antioxidant, anti-inflammatory, and antidepressant properties. In modern times, saffron and its constituents have been utilized, alone and in TCM formulas, to treat neuropsychiatric and neurodegenerative diseases. In this review, we mainly focus on recent clinical and preclinical trials of brain disorders in which saffron was applied, and summarize the neuroprotective properties of saffron and its constituents from chemical, pharmacokinetic, and pharmacological perspectives. We discuss the properties of saffron and its constituents, as well as their applications for treating brain disorders; we hope that this review will serve as a comprehensive reference for studies aimed at developing therapeutic drugs based on saffron.
引用
收藏
页数：13
相关论文
共 142 条
[1]   Neuroprotection by crocetin in a hemi-parkinsonian rat model [J].
Ahmad, AS ;
Ansari, MA ;
Ahmad, M ;
Saleem, S ;
Yousuf, S ;
Hoda, MN ;
Islam, F .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2005, 81 (04) :805-813
[2]   Crocetin inhibits beta-amyloid fibrillization and stabilizes beta-amyloid oligomers [J].
Ahn, Joon Ho ;
Hu, Yang ;
Hernandez, Michael ;
Kim, Jin Ryoun .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2011, 414 (01) :79-83
[3]   Crocus sativus L. in the treatment of mild to moderate depression:: A double-blind, randomized and placebo-controlled trial [J].
Akhondzadeh, S ;
Tahmacebi-Pour, N ;
Noorbala, AA ;
Amini, H ;
Fallah-Pour, H ;
Jamshidi, AH ;
Khani, M .
PHYTOTHERAPY RESEARCH, 2005, 19 (02) :148-151
[4]   Saffron in the treatment of patients with mild to moderate Alzheimer's disease: a 16-week, randomized and placebo-controlled trial [J].
Akhondzadeh, S. ;
Shafiee-Sabet, M. ;
Harirchian, M. H. ;
Togha, M. ;
Cheraghmakani, H. ;
Razeghi, S. ;
Hejazi, S. Sh ;
Yousefi, M. H. ;
Alimardani, R. ;
Jamshidi, A. ;
Zare, F. ;
Moradi, A. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (05) :581-588
[5]   Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: A pilot double-blind randomized trial [ISRCTN45683816] [J].
Akhondzadeh S. ;
Fallah-Pour H. ;
Afkham K. ;
Jamshidi A.-H. ;
Khalighi-Cigaroudi F. .
BMC Complementary and Alternative Medicine, 4 (1)
[6]   A 22-week, multicenter, randomized, double-blind controlled trial of Crocus sativus in the treatment of mild-to-moderate Alzheimer's disease [J].
Akhondzadeh, Shahin ;
Sabet, Mehdi Shafiee ;
Harirchian, Mohammad Hossein ;
Togha, Mansoreh ;
Cheraghmakani, Hamed ;
Razeghi, Soodeh ;
Hejazi, Seyyed Shamssedin ;
Yousefi, Mohammad Hossein ;
Alimardani, Roozbeh ;
Jamshidi, Amirhossein ;
Rezazadeh, Shams-Ali ;
Yousefi, Aboulghasem ;
Zare, Farhad ;
Moradi, Atbin ;
Vossoughi, Ardalan .
PSYCHOPHARMACOLOGY, 2010, 207 (04) :637-643
[7]  
Amin B, 2015, AVICENNA J PHYTOMEDI, V5, P458
[8]   Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease [J].
Arabia, Gennarina ;
Grossardt, Brandon R. ;
Geda, Yonas E. ;
Carlin, Justin M. ;
Bower, James H. ;
Ahlskog, J. Eric ;
Maraganore, Demetrius M. ;
Rocca, Walter A. .
ARCHIVES OF GENERAL PSYCHIATRY, 2007, 64 (12) :1385-1392
[9]   Reversal effects of crocin on amyloid β-induced memory deficit: Modification of autophagy or apoptosis markers [J].
Asadi, Farideh ;
Jamshidi, Amir Hossein ;
Khodagholi, Fariba ;
Yans, Asal ;
Azimi, Leila ;
Faizi, Mehrdad ;
Vali, Leila ;
Abdollahi, Mohammad ;
Ghahremani, Mohammad Hossein ;
Sharifzadeh, Mohammad .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2015, 139 :47-58
[10]   Protective properties of the aqueous extract of saffron (Crocus sativus L.) in ischemic stroke, randomized clinical trial [J].
Asadollahi, Mostafa ;
Nikdokht, Parisa ;
Hatef, Boshra ;
Sadr, Seyed Shahabeddin ;
Sahraei, Hedayat ;
Assarzadegan, Farhad ;
Jahromi, Gila Pirzad .
JOURNAL OF ETHNOPHARMACOLOGY, 2019, 238
12345678910